Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04918290 · ClinicalTrials.gov registry record · NA

Tegaderm Vs. Transpore for Eye Protection During Anesthesia

A NA study, sponsored by Tufts Medical Center.

Completed
Registry status
NA
Development phase
165
Enrollment target

NCT04918290: Completed NA study, sponsored by Tufts Medical Center.

NCT04918290 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04918290, a NA study, has completed, sponsored by Tufts Medical Center.

COMPLETED
Registry status
NA
Development phase
165 participants
Enrollment target

Study Summary

The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar between the two groups given there is no evidence currently to suggest otherwise

Primary Outcome

Degree of erythema seen in the photo taken of the eyelid immediately after the tape is removed after surgery

Interventions

  • DEVICE Tegaderm Eye Tape
  • DEVICE Transpore Eye Tape

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2021-06-11
Est. Completion 2024-05-15
Phase NA
Tufts Medical Center

169 total trials

What the finished NCT04918290 record still lists

NCT04918290 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which Tegaderm Eye Tape is the first listed.

NCT04918290 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04918290 about?

NCT04918290 is a clinical study titled "Tegaderm Vs. Transpore for Eye Protection During Anesthesia". The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar between the two groups given there is no evidence currently to suggest otherwise

What is the current status of trial NCT04918290?

This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2021-06-11. Estimated completion is 2024-05-15.

What interventions are being tested in trial NCT04918290?

The interventions under investigation include: Tegaderm Eye Tape (DEVICE), Transpore Eye Tape (DEVICE).

Who is sponsoring clinical trial NCT04918290?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04918290's enrollment target sits among peer trials

165 626th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02387255 · 165 participants

    Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms

  • NCT03351348 · 165 participants · Phase 3

    Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

  • NCT03830320 · 165 participants · Phase 1

    Positron Emission Tomography (PET) Imaging of Thrombosis

  • NCT04289571 · 165 participants · Phase 1

    Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04918290, the US trial registry maintained by the National Library of Medicine. NCT04918290 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.